Oral resveratrol supplementation improves Metabolic Syndrome features in obese patients submitted to a lifestyle-changing program

Life Sci. 2020 Sep 1:256:117962. doi: 10.1016/j.lfs.2020.117962. Epub 2020 Jun 11.

Abstract

Aims: The aim of the present study was to evaluate the oral resveratrol effects associated with diet and physical training changes on anthropometric and biochemical parameters.

Main methods: 25 individuals aged from 30 to 60 years old; with Body Mass Index (BMI) ≥ 30 kg/m2 were included in the study. Following the primary evaluation (anthropometric and clinical), the patients were randomly divided into 2 groups: (1) Placebo: Physical activity program + Diet + Placebo; (2) Resveratrol: Physical activity program + Diet + Resveratrol (RVS) (250 mg/day) for three months. Anthropometric and biochemical parameters were evaluated at baseline and after the treatment period.

Key findings: The main findings showed that the resveratrol supplementation improved total cholesterol (TC), High-density Lipoprotein cholesterol (HDL-c), Very-low density Lipoprotein cholesterol (VLDL-c), urea, creatinine and albumin serum levels.

Significance: These findings indicate that this polyphenol may be an option to potentiate the beneficial effects induced by dietary and physical activity programs in the Metabolic Syndrome (MetS) treatment.

Keywords: Adipose tissue; Diabetes; Diet; MetS; Obesity; Physical activity; Polyphenols; Sirt1; Sirtuins.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Administration, Oral
  • Adult
  • Dietary Supplements*
  • Energy Metabolism / drug effects
  • Female
  • Humans
  • Life Style*
  • Lipids / blood
  • Male
  • Metabolic Syndrome / blood
  • Metabolic Syndrome / complications*
  • Metabolic Syndrome / drug therapy*
  • Middle Aged
  • Obesity / blood
  • Obesity / complications*
  • Placebos
  • Resveratrol / administration & dosage*
  • Resveratrol / therapeutic use*

Substances

  • Lipids
  • Placebos
  • Resveratrol